Seroatlas · Human Serome Atlas

HSF2BP

Heat shock factor 2-binding protein

Also known as: HSF2B_HUMAN, MEILB2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O75031
Gene
HSF2BP
Ensembl
ENSG00000160207
Chromosome
21
Canonical length
334 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Cytosol

OverviewNCBI Gene

HSF2 binding protein (HSF2BP) associates with HSF2. The interaction occurs between the trimerization domain of HSF2 and the amino terminal hydrophilic region of HSF2BP that comprises two leucine zipper motifs. HSF2BP may therefore be involved in modulating HSF2 activation. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

334 residues, UniProt reviewed canonical sequence.

>O75031|HSF2BP
     1  MGEAGAAEEA CRHMGTKEEF VKVRKKDLER LTTEVMQIRD FLPRILNGEV LESFQKLKIV
    61  EKNLERKEQE LEQLKMDCEH FKARLETVQA DNIREKKEKL ALRQQLNEAK QQLLQQAEYC
   121  TEMGAAACTL LWGVSSSEEV VKAILGGDKA LKFFSITGQT MESFVKSLDG DVQELDSDES
   181  QFVFALAGIV TNVAAIACGR EFLVNSSRVL LDTILQLLGD LKPGQCTKLK VLMLMSLYNV
   241  SINLKGLKYI SESPGFIPLL WWLLSDPDAE VCLHVLRLVQ SVVLEPEVFS KSASEFRSSL
   301  PLQRILAMSK SRNPRLQTAA QELLEDLRTL EHNV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against HSF2BP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.36
Highest tissue expression
23 nTPM

Expression across tissuesHPA

Tissue

  • testis: 23 nTPM
  • cerebral cortex: 2.3 nTPM
  • midbrain: 1.2 nTPM
  • spinal cord: 1.2 nTPM
  • ovary: 1 nTPM
  • amygdala: 0.9 nTPM

Single-cell type

  • early spermatids: 107 nCPM
  • early primary spermatocytes: 88 nCPM
  • late primary spermatocytes: 48 nCPM
  • differentiating spermatogonia: 46 nCPM
  • late spermatids: 45 nCPM
  • undifferentiated spermatogonia: 30 nCPM

Immune cell

  • naive CD4 T-cell: 0.7 nTPM
  • naive CD8 T-cell: 0.7 nTPM
  • MAIT T-cell: 0.4 nTPM
  • NK-cell: 0.4 nTPM
  • memory B-cell: 0.3 nTPM
  • memory CD8 T-cell: 0.3 nTPM

Brain region

  • cerebral cortex: 4.4 nTPM
  • hypothalamus: 2.8 nTPM
  • thalamus: 2.8 nTPM
  • white matter: 2.8 nTPM
  • pons: 2.7 nTPM
  • medulla oblongata: 2.6 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about HSF2BP.

Disease | AllUniProt

Conditions HSF2BP is implicated in, by any mechanism.

Disease | GeneticClinVar

2 pathogenic / likely-pathogenic of 59 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.81
gnomAD pLI
0
gnomAD missense Z
-0.17
DepMap mean gene effect
0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of HSF2BP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads HSF2BP as an antibody target. Whether an autoantibody or antibody against HSF2BP could matter depends on whether native HSF2BP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

HSF2BP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label HSF2BP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/HSF2BP. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...